= No Continuing Education
Date:Tuesday, October 16, 2012
Time:2:00 - 3:00 pm (Eastern Time)
Presenter(s)
Melissa K. Schaefer, MD
Medical Officer
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease and Control and Prevention
Tom Chiller, MD, MPH
Medical Epidemiologist
Division of Foodborne, Waterborne & Environmental Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease and Control and Prevention
Peter G. Pappas, MD
Professor of Medicine
Division of Infectious Disease
Department of Medicine
University of Alabama at Birmingham
Overview
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to work closely with state public health departments on a multistate investigation of fungal meningitis among patients who received an epidural steroid injection. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center (NECC), located in Framingham, Mass. During this COCA Call, subject matter experts will provide updates to the current epidemiology of the outbreak, describe clinical presentation and features of fungal meningitis, and review CDC’s recommended treatment guidance.
Call Materials
Additional Resources
Call Format
- Live audio conference call on 10/16/12: 2:00 - 3:00 PM
- Web-on-demand training after 3:00 PM on 10/16/12
Additional Call Information
Continuing Education
Target Audience
- Physicians
- Nurses
- Pharmacists
- Veterinarians
- Physician Assistants
- Health Educators
- Other Clinicians
Hardware/Software
Additional Information
- Contact Information:coca@cdc.gov
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communications Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.
- Fees:COCA continuing education credits are free.